Glyburide and Movement disorder - a phase IV clinical study of FDA data

Summary:

Movement disorder is reported as a side effect among people who take Glyburide (glyburide), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Hydrochlorothiazide, and have Carcinoid tumor.

The phase IV clinical study analyzes which people have Movement disorder when taking Glyburide. It is created by eHealthMe based on reports of 37,840 people who have side effects when taking Glyburide from the FDA, and is updated regularly.

What is Glyburide?

Glyburide has active ingredients of glyburide. It is often used in diabetes. eHealthMe is studying from 38,448 Glyburide users. Check the latest studies of Glyburide.

What is Movement disorder?

Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness) is found to be associated with 1,381 drugs and 1,500 conditions by eHealthMe. Check the latest studies of Movement disorder.

On Jul, 11, 2026

37,840 people reported to have side effects when taking Glyburide.
Among them, 84 people (0.22%) have Movement disorder.

Could Glyburide cause Movement disorder?

Among these 84 people:

How long have people been on Glyburide when they have Movement disorder? *

What is the gender of people who have Movement disorder when taking Glyburide? *

female: 39.02 %
male: 60.98 %

What is the age of people who have Movement disorder when taking Glyburide? *

What are other drugs people take besides Glyburide? *

Metformin: 24 people, 28.57%
Hydrochlorothiazide: 24 people, 28.57%
Imodium: 21 people, 25.00%
Sandostatin: 21 people, 25.00%
Zopiclone: 19 people, 22.62%
Altace: 19 people, 22.62%
Metformin Hydrochloride: 18 people, 21.43%
Quinapril: 17 people, 20.24%
Linagliptin: 17 people, 20.24%
Amlodipine Besylate: 13 people, 15.48%

What are other side effects people have besides Movement disorder? *

Nausea (feeling of having an urge to vomit): 27 people, 32.14%
Blood Glucose Increased: 27 people, 32.14%
Diarrhea: 26 people, 30.95%
Fainting (loss of consciousness and postural tone): 24 people, 28.57%
Nausea And Vomiting: 23 people, 27.38%
Haematocrit Decreased: 22 people, 26.19%
Blood Pressure Systolic Increased: 21 people, 25.00%
Haemoglobin Decreased: 20 people, 23.81%
Glycosylated Haemoglobin Increased: 20 people, 23.81%
Blood Potassium Decreased: 20 people, 23.81%

What are the existing conditions these people have? *

Carcinoid Tumor: 19 people, 22.62%
Neuroendocrine Tumor: 18 people, 21.43%
High Blood Cholesterol: 9 people, 10.71%
Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 7 people, 8.33%
High Blood Pressure: 5 people, 5.95%
Blood Pressure Abnormal: 4 people, 4.76%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 4 people, 4.76%
Restless Leg Syndrome (a powerful urge to move your legs): 4 people, 4.76%
Pain: 3 people, 3.57%
Thyroid Diseases: 3 people, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Glyburide and have Movement disorder?

- Check whether Movement disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Glyburide:

Glyburide (38,448 reports)

Browse all side effects of Glyburide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Movement disorder:

Movement disorder (1,381 drugs)

Browse all the conditions that are associated with Movement disorder:

Movement disorder (1,500 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on glyburide (the active ingredients of Glyburide) and Glyburide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.